Descrizione

The rapid pathogen detection market in USA is set to increase by US$ 178.3 milioni da 2022 A 2028, che rappresenta un tasso di crescita annuale composto (CAGR) Di 6.8% durante il periodo di previsione.

Il rapporto fornisce dati aggiornati sulle dimensioni del mercato per il periodo 2018-2021 e previsione a 2028 covering key market aspects like sales value for rapid pathogen detection. The USA rapid pathogen detection market is segmented on the basis of product, and testing method. In base al prodotto, the rapid pathogen detection market in USA has been segmented into detection devices, sensori. The detection devices segment is estimated to account for the largest share of the rapid pathogen detection market in USA. By testing method, the rapid pathogen detection market in USA has been segmented into immunological analysis, mass spectrometry, polymerase chain reaction (PCR). The immunological analysis segment held the largest revenue share in 2021.

The detection device market is further segmented into handheld, installed, portable, and tabletop. The handheld segment held the largest share of the USA rapid pathogen detection market in 2021 e si prevede che manterrà la sua quota durante il periodo di previsione.

The USA rapid pathogen detection market is highly competitive. Top players covered in USA Rapid Pathogen Detection Market Study are ANP Technologies Inc., Battelle, Bavarian Nordic A/S, BioMerieux S.A., Bruker Detection Corp, Corgenix Medical Corp., Electronic Sensor Technology Inc., Emergent BioSolutions Inc., Eurofins Scientific, GlaxoSmithKline plc (GSK), InBios International Inc., Inovio Pharmaceuticals Inc., LGC Biosearch Technologies, Merck KGaA, Novavax Inc., Soligenix Inc., Thermo Fisher Scientific Inc.

Il rapporto è una risorsa inestimabile per le aziende e le organizzazioni attive in questo settore. It provides a cohesive picture of the rapid pathogen detection market to help drive informed decision making for industry executives, decisori politici, accademico, e analisti.

Ambito del rapporto

Prodotto: detection devices, sensori
Testing method: immunological analysis, mass spectrometry, polymerase chain reaction (PCR)
Anni considerati: la presente relazione copre il periodo 2018 A 2028

Principali vantaggi per gli stakeholder

– Get a comprehensive picture of the USA rapid pathogen detection market
– Identificare le strategie regionali e le priorità strategiche sulla base dei dati locali
– Individuare i settori in crescita e le tendenze per gli investimenti

Sommario

Parte 1. introduzione
– Ambito dello studio
– Periodo di studio
– Ambito geografico
– Metodologia di ricerca
Parte 2. Rapid pathogen detection market overview
Parte 3. Ripartizione del mercato per prodotto
– Detection devices
– Sensors
Parte 4. Market breakdown by testing method
– Immunological analysis
– Mass spectrometry
– Polymerase chain reaction (PCR)
Parte 5. Aziende chiave
– ANP Technologies, Inc.
– Battelle
– Bavarian Nordic A/S
– BioMerieux, SA.
– Bruker Detection Corp
– Corgenix Medical Corp.
– Electronic Sensor Technology, Inc.
– Emergent BioSolutions Inc.
– Eurofins Scientific
– GlaxoSmithKline plc (GSK)
– InBios International, Inc.
– Inovio Pharmaceuticals, Inc.
– LGC Biosearch Technologies
– Merck KGaA
– Novavax, Inc.
– Soligenix, Inc.
– Thermo Fisher Scientific Inc.
Informazioni su StrategyHelix
Disclaimer